Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: Meta‐analysis of randomized controlled trials

BACKGROUND: The combination of vitamin K antagonists (VKA) for atrial fibrillation (AF) and antiplatelet agents following percutaneous coronary intervention (PCI) is associated with an increased bleeding risk. HYPOTHESIS: Direct oral anticoagulants (DOAC) are associated with a greater safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Roule, Vincent, Ardouin, Pierre, Briet, Clément, Lemaitre, Adrien, Bignon, Mathieu, Sabatier, Rémi, Champ‐Rigot, Laure, Milliez, Paul, Blanchart, Katrien, Beygui, Farzin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727878/
https://www.ncbi.nlm.nih.gov/pubmed/31290171
http://dx.doi.org/10.1002/clc.23224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727878/
https://www.ncbi.nlm.nih.gov/pubmed/31290171
http://dx.doi.org/10.1002/clc.23224

Ejemplares similares